These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31799361)

  • 81. Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations.
    Kaserer A; Schedler A; Seifert B; Spahn DR; Studt JD; Stein P
    Perioper Med (Lond); 2019; 8():15. PubMed ID: 31832179
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A; Barbaste C; Gabaig AM; Trumel C; Abella-Bourges N; Guelfi JF; Bousquet Mélou A
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
    Tschaikowsky K; Balint R; Pscheidl E; Bremer F
    Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.
    Oladunjoye OO; Sleeper LA; Nair AG; Trenor CC; VanderPluym C; Kheir JN; Emani SM
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):332-340.e1. PubMed ID: 29709361
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
    Mineo HK; Garabed RB
    Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW; Vondracek TG
    Pharmacotherapy; 2012 Jun; 32(6):546-58. PubMed ID: 22531940
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Monitoring unfractionated heparin therapy. 4 hour-stability of anti-Xa activity in unspun citrated tubes.
    Toulon P; Appert-Flory A; Fischer F; Buvat S; Jambou D; Mahagne MH
    Thromb Res; 2020 Feb; 186():7-12. PubMed ID: 31837560
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
    Takemoto CM; Streiff MB; Shermock KM; Kraus PS; Chen J; Jani J; Kickler T
    Am J Clin Pathol; 2013 Apr; 139(4):450-6. PubMed ID: 23525615
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
    Salvagno GL; Lippi G; Montagnana M; Franchini M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):462-7. PubMed ID: 18371059
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
    Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Hornykewycz S; Michitsch A; Huber K; Clemens D; Susan M; Pabinger I; Eichinger S; Jilma B; Speiser W
    Thromb Res; 1997 Sep; 87(5):431-40. PubMed ID: 9306617
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Retrospective cohort study comparing activated partial thromboplastin time versus anti-factor Xa activity nomograms for therapeutic unfractionated heparin monitoring in pediatrics.
    Trucco M; Lehmann CU; Mollenkopf N; Streiff MB; Takemoto CM
    J Thromb Haemost; 2015 May; 13(5):788-94. PubMed ID: 25740425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
    Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
    Renda G; Di Pillo R; D'Alleva A; Sciartilli A; Zimarino M; De Candia E; Landolfi R; Di Giammarco G; Calafiore A; De Caterina R
    Haematologica; 2007 Mar; 92(3):366-73. PubMed ID: 17339186
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Monitoring unfractionated heparin therapy: Lack of standardization of anti-Xa activity reagents.
    Smahi M; De Pooter N; Hollestelle MJ; Toulon P
    J Thromb Haemost; 2020 Oct; 18(10):2613-2621. PubMed ID: 32573889
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effects of pre-analytical variables on the anti-activated factor X chromogenic assay when monitoring unfractionated heparin and low molecular weight heparin anticoagulation.
    McGlasson DL; Kaczor DA; Krasuski RA; Campbell CL; Kostur MR; Adinaro JT
    Blood Coagul Fibrinolysis; 2005 Apr; 16(3):173-6. PubMed ID: 15795534
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Verification of the ACL Top 50 Family (350, 550, and 750) for Harmonization of Routine Coagulation Assays in a Large Network of 60 Laboratories.
    Favaloro EJ; Mohammed S; Vong R; McVicker W; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Prasad R; Brighton T; Pasalic L
    Am J Clin Pathol; 2021 Sep; 156(4):661-678. PubMed ID: 33891005
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Monitoring of unfractionated heparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent (PiCT®).
    Schaden E; Jilch S; Hacker S; Schober A; Kozek-Langenecker S
    Clin Chim Acta; 2012 Dec; 414():202-5. PubMed ID: 23041210
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.